NEVIRAPINE 200 MG TABLET

Nevirapine
$0.1314per EA

Strength

200 mg/1

NDC

65862002760

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

8/20/2025

Active Ingredients

NEVIRAPINE

Approval Type

Generic (ANDA)

FDA Application

ANDA077521

On Market Since

5/22/2012

Pharmacological Classes

Cytochrome P450 2B6 Inducers
Cytochrome P450 3A Inducers
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
Non-Nucleoside Analog
Non-Nucleoside Reverse Transcriptase Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

+6.8%

3Y

-5.2%

5Y

-5.2%

All

-28.7%